Melle C, Osterloh D, Ernst G, Schimmel B, Bleul A, von Eggeling F: Identification of proteins from colorectal cancer tissue by two-dimensional gel
electrophoresis and SELDI mass spectrometry. Int J Mol Med 2005, 16:11–17.PubMed 29. Lou J, Fatima N, Xiao Z, Stauffer S, Smythers G, Greenwald P, Ali IU: Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells. Cancer Epidemiol Biomarkers Prev 2006, 15:1598–1606.PubMedCrossRef 30. Wong CS, Wong VW, Chan CM, Ma BB, Hui EP, Wong MC, Lam MY, Au TC, Chan WH, Cheuk W, Chan AT: Identification of 5-fluorouracil BIX 1294 solubility dmso response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Oncol Rep 2008, 20:89–98.PubMed 31. Chen J, He QY, Yuen AP, Chiu JF: Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004, 24:2465–2475.CrossRef 32. Qi
YJ, He QY, Ma YF, Du YW, Liu GC, Li YJ, Tsao GS, Ngai SM, Chiu JF: Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma. J Cell Biochem 2008, 104:1625–1635.PubMedCrossRef 33. Al-Ghoul M, Brück TB, Lauer-Fields JL, Asirvatham VS, Zapata C, Kerr RG, Fields GB: Comparative proteomic analysis of matched primary and metastatic melanoma cell lines. J Proteome Res 2008, 27:4107–4118.CrossRef 34. Han X, Yoon SH, Ding Y, Choi TG, Choi WJ, Kim YH, Kim YJ, Huh YB, Ha J, Kim SS: Cyclosproin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells. Oncol Rep 2010, FHPI ic50 23:1053–1062.PubMedCrossRef 35. Weisinger G, Gavish M, Mazurika C, Zinder O: Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes:
Tissue- and treatment-specificity. Biochimica et Biophysica Acta – Gene Structure and Expression 1999,1446(3):225–232.CrossRef 36. Choi KJ, Piao YJ, Lim MJ, Kim JH, Ha J, Choe W, Kim SS: Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- Tolmetin and cisplatin-induced cell death. Cancer Res 2007, 67:3654–3662.PubMedCrossRef 37. Gu S, Liu Z, Pan S, Jiang Z, Lu H, Amit O, Bradbury EM, Hu C A, Chen X: Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. Mol Cell Proteomics 2004, 3:998–1008.PubMedCrossRef 38. Yu X, Harris SL, Levine AJ: The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 2006, 66:4795–4801.PubMedCrossRef 39. Mantovani F, Tocco F, Girardini J, Smith P, Gasco M, Lu X, Crook T, Del Sal G: The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol 2007, 14:912–920.PubMedCrossRef 40. Chaurand P, Rahman MA, Hunt T, Mobley JA, Gu G, Latham JC, Caprioli RM, Kasper S: Monitoring mouse prostate development by profiling and imaging mass spectrometry. Molecular & Cellular Proteomics 2008, 7:411–423.